Copyright © 2018 ReVivo Medical. All Rights Reserved.
President and Chief Executive Officer
About the Company
The initial products are strategically designed to enhance visibility during surgery and eliminate some of the most common complications.
Chief Medical Officer
Biomedical Acceleration and Commercialization Center (BACC)
Albany Medical College
43 New Scotland Avenue (MC 25)
Albany, NY 12208
Chief Technology Officer
Chief Science Officer
The proprietary design increases value while decreasing the costs associated with spinal fusion.
In a recent efficacy study, our anterior cervical plate showed a 46% improvement in bone growth, and a superior rate and quality of fusion over the commonly used dynamic plate. The results of this study were published in The Spine Journal and can be seen here.
ReVivo Medical was founded in 2011 by Darryl J. DiRisio, MD; Glenn P. Sanders, Ph.D.; and Eric H. Ledet, Ph.D.
From their extensive experience gained in the operating room and through thousands of hours in the research laboratory, they identified the substantial need to improve spinal fusion for all stakeholders.
ReVivo Medical’s products enhance treatments for back, neck, and spine-related pain through thoroughly tested, innovative designs that improve patient outcomes, reduce surgical complications, and decrease costs. ReVivo’s initial family of products targets the $5 billion spinal fusion market.
ReVivo’s innovative flagship product-line for the spinal fusion market offers competitive advantages to the patient, surgeon, hospital, and healthcare system.
Meet our Founders
Since 2011, ReVivo Medical's mission has been to improve treatments for back, neck, and spine-related pain.
Our implants leverage the basic science and understanding of spinal fusions for faster and better fusion.
ReVivo has been issued four patents that broadly protect our elastic micro-motion technology and unique design features. In addition, fourteen US and international patents are pending, covering a wide spectrum of devices and instrumentation. The issued patents can be viewed by clicking on the following: US 9,510,871; US 9,788,864; US 9,795,414; US 9,861,392
Our implants eliminate redundant steps of the surgical process, leading to improved surgeon productivity and hospital efficiency.